Success (n = 78) | Failure (n = 23) | p-value | |
---|---|---|---|
Age (years) | 74.2 ± 8.6 | 73.4 ± 8.2 | 0.679 |
Female | 63 (80.8) | 18 (78.3) | 0.772 |
BMI (kg/m2) | 27 ± 4.9 | 26 ± 3.5 | 0.381 |
Diabetes | 37 (47.4) | 11 (47.8) | 0.974 |
CCI | 3.7 ± 1.4 | 3.5 ± 0.8 | 0.577 |
Symptom duration (days) | 7.3 ± 7.6 | 9.3 ± 8.4 | 0.267 |
Operation | |||
Primary | 71 (90) | 19 (83) | 0.462 |
Revision | 8 (10) | 4 (17) | |
Implant age (Month)* | 8.0 (1.0–33.0) | 11.0 (5.0–35.5) | 0.545 |
Preoperative CRP | 11.6 ± 8.5 | 16.6 ± 12.5 | 0.082 |
Type of organism | |||
Staphylococcus aureus | 15 (19.5) | 6 (26.1) | 0.139 |
Antibiotic resistant (MRSA, MRSE) | 12 (15.6) | 5 (21.7) | |
Streptococcus | 17 (22.1) | 3 (13.0) | |
Enterococcus | 2 (2.6) | 0 (0.0) | |
Candida | 2 (2.6) | 1 (4.3) | |
Gram negative | 8 (10.4) | 3 (13.0) | |
Polymicrobial | 1 (1.3) | 3 (13.0) | |
Culture negative | 20 (26.0) | 2 (8.7) | |
Type of infection | |||
Acute postsurgical PJI | 30 (38) | 4 (17) | 0.060 |
Acute hematogenous PJI | 48 (62) | 19 (83) |